Seref Alpsoy

Seref Alpsoy

Auto-generated profile, based on publicly available information

Seref Alpsoy

Department of Cardiology, Tekirdag Namik Kemal University, Tekirdag, Turkey

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2014 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
GEGamze Erfan
Gamze Erfan
SGSavas Guzel
Savas Guzel
SASeref Alpsoy
Seref Alpsoy
EREmine N. Rifaioglu
Emine N. Rifaioglu
SKSule Kaya
Sule Kaya
MKMustafa Kulac
Mustafa Kulac

29 July 2020 in Clinical and Experimental Hypertension
Verified
Journal Article
Closed access
SASeref Alpsoy
Seref Alpsoy
BDBurcin Dogan
Burcin Dogan
DGDemet Ozkaramanli Gur
Demet Ozkaramanli Gur
AAAydin Akyüz
Aydin Akyüz
ÇFÇiğdem Fidan
Çiğdem Fidan
BOBerna Ozkoyuncu
Berna Ozkoyuncu
The pathophysiology of non-dipper hypertension has not been clarified. The relationship between salusins with atherosclerosis and hypertension has gained attention in recent years. The aim of this paper is to investigate whether salusins are associated with circadian blood pressure, left ventricular mass index, and diastolic functions in newly diagnosed hypertensives. The study included 88 newly diagnosed hypertensive individuals. Twenty-four-hour ambulatory blood pressure monitoring and echocardiographic examinations were performed. The patients were assigned to dipper hypertension (n = 41) and non-dipper hypertension (n = 47) groups based on the ambulatory blood pressure monitoring results according to the presence of ≥ a 10% decrease in nighttime blood pressure values or not. Serum salusin α and β levels were determined by electrochemiluminescence immunological test method. Compared to dipper hypertension, non-dipper hypertension group demonstrated lower salusin α levels (1818.71 ± 221.67 vs 1963 ± 200.75 pg/mL, p = .002), mitral E/A, septal E’/A’ and higher salusin β levels (576.24 ± 68.15 vs 516.13 ± 90.7 pg/ml, p = .001) and left ventricular mass index. Multivariate logistic regression analysis revealed salusin-α (OR 0.474, 95% CI 0.262 to 0.986, p = .001), salusin-β (OR 2.550, 95% CI 2.123 to 2.991, p = .018), and left ventricular mass index (OR 2.620, 95% CI 2.124 to 2.860, p = .011) as independent predictors of non-dipper hypertension. As candidate markers to predict non-dipper hypertension, decreased salusin α, and increased salusin β levels may mediate crosstalk between sympathetic and parasympathetic systems and indicate poor cardiovascular prognosis in hypertension.

1 April 2014
Verified
Journal Article
Closed access
SAS Alpsoy
S Alpsoy
AAA Akyuz
A Akyuz
GEGamze Erfan
Gamze Erfan
DAD C Akkoyun
D C Akkoyun
BTB Topcu
B Topcu
MKM Kulac
M Kulac

13 June 2021 in Clinical and Experimental Hypertension
Verified
Journal Article
Closed access
ŞAŞeref Alpsoy
Şeref Alpsoy
SGSümeyra Gökçek
Sümeyra Gökçek
DGDemet Özkaramanlı Gür
Demet Özkaramanlı Gür
AAAydın Akyüz
Aydın Akyüz
An association between increased mean platelet volume (MPV) and cardiovascular events is well established. Recent studies suggest that a nondipper blood pressure pattern is closely related to incre...

6 April 2017 in Electronic Journal of General Medicine
Verified
Journal Article
Open access
BBBulent Bilir
Bulent Bilir
DADursun Cayan Akkoyun
Dursun Cayan Akkoyun
MAMurat Aydin
Murat Aydin
DODemet Ozkaramanli-Gur
Demet Ozkaramanli-Gur
HDHasan Degirmenci
Hasan Degirmenci
OEOzcan Erel
Ozcan Erel

1 June 2015 in Blood Pressure Monitoring
Verified
Journal Article
Closed access
DADursun C. Akkoyun
Dursun C. Akkoyun
AAAydin Akyuz
Aydin Akyuz
SASeref Alpsoy
Seref Alpsoy
MAMurat Aydin
Murat Aydin
KEKubilay Erselcan
Kubilay Erselcan
Cardiovascular diseases are more common in patients with nondipper hypertension (NDHT) compared with those with dipper hypertension (DHT). The aim of this study is to evaluate the serum neurokinin B levels in DHT and NDHT patients.The study population included newly diagnosed hypertensive patients who were not under antihypertensive treatment. A total of 77 patients were evaluated with ambulatory blood pressure monitoring and divided into two groups: NDHT (n=42) and DHT (n=35). Plasma neurokinin B levels were measured using the ELISA method.Serum neurokinin B levels were significantly higher in the NDHT group compared with the DHT group [254 (180-888) and 207 (116-752) pg/ml, respectively; P=0.024]. There is a positive correlation between the mean night-time systolic blood pressure and plasma neurokinin levels (r=0.590; P<0.001). On regression analysis, neurokinin B level was only found to be related to the mean night-time systolic blood pressure (unstandardized β=-22.02±9.59; P<0.001).Plasma neurokinin B level is higher in patients with NDHT, indicating an unfavorable cardiovascular prognosis. There is a need for further studies that search for the relation between serum neurokinin B levels and NDHT.